AI Closed-Loop Drug Discovery
Forecast drug-discovery systems that combine generative models, robotic synthesis, automated assays, and active learning to optimize candidates.
Core metadata
- ID: ai_closed_loop_drug_discovery
- Era: Future
- First known date: 2040 (decade)
- Region: Forecast / global pharmaceutical research
- Review status: source_checked
- Maturity: forecast
Prerequisites
- End-to-End AI Drug Discovery (ai_driven_drug_discovery)
- Computer-Aided Drug Design (computer_aided_drug_design)
- High-Throughput Screening (high_throughput_screening)
Dependents
- None.
Fields
Field lanes
- Pharmaceuticals & Drug Development: Roadmap
Node sources
- The rise of self-driving labs in chemical and materials sciences (Nature Synthesis, 2023, review) • Supports: node, roadmap, maturity
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 3
- Average edge confidence: 37%
- Prerequisite sources: 3
- speculative: 3
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| End-to-End AI Drug Discovery (ai_driven_drug_discovery) | speculative | 40% | speculative | Closed-loop drug discovery is modeled as a forecast extension of AI-assisted discovery rather than an established production path. |
|
| High-Throughput Screening (high_throughput_screening) | speculative | 35% | speculative | High-Throughput Screening is a plausible dependency for a forecast technology and should be treated as speculative. |
|
| Computer-Aided Drug Design (computer_aided_drug_design) | speculative | 35% | speculative | Computer-Aided Drug Design is a plausible dependency for a forecast technology and should be treated as speculative. |
|
This page is generated from canonical era JSON and is indexable by URL.